Skip to content

Effects of a TCM-Based Intervention Incorporating Preventive Treatment and Emotional Regulation in Young and Middle-Aged Adults with Borderline Hypertension: A Prospective, Randomized Controlled Trial

Efficacy of Auricular Holographic Therapy Combined with Acupoint Application in Young and Middle-Aged Patients with Borderline Hypertension: A Prospective, Randomized Controlled Trial Based on the TCM Concept of Preventive Treatment of Disease and Emotional Regulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002074
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-09-08
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prehypertension

Interventions

Intervention group:Received TCM-based lifestyle intervention plus Auricular Holographic Therapy combined with Acupoint Application.
Control group:Received TCM-based lifestyle intervention alone

Sponsors

Chengdu Integrated TCM & Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1)Participants met at least one syndrome type defined in the Expert Consensus on TCM Diagnosis and Treatment of Hypertension and had a mean 24-hour ambulatory blood pressure ranging from 120 to 139/80 to 89 mmHg without antihypertensive medication. (2)Participants were aged 18 to 55 years, consistent with the demographic characteristics for young and middle-aged adults as referenced in the Chinese Guidelines for Hypertension Prevention and Treatment. (3)All participants voluntarily provided written informed consent to enroll in the study. (4)Participants demonstrated the ability to adhere to health guidance provided by healthcare professionals.

Exclusion criteria

Exclusion criteria: (1)Patients with severe dysfunction of major organs (e.g., hepatic, renal, or cerebral) or significant systemic diseases. (2)Individuals with diagnosed psychiatric disorders. (3)Women who were pregnant or lactating. (4)Participants who were concurrently enrolled in other similar clinical trials.

Design outcomes

Secondary

MeasureTime frame
Patient Adherence;Adverse Event Incidence Rate;

Primary

MeasureTime frame
Blood pressure;TCM Syndrome Score;Therapeutic Efficacy of TCM Syndromes;Self-Management Capacity;Quality of Life ;Anxiety;Sleep Quality;

Countries

China

Contacts

Public ContactTairong Zheng

Chengdu Integrated TCM & Western Medicine Hospital

402160852@qq.com18711390170

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026